X4 Pharmaceuticals, Inc (XFOR) Operating Lease, Right-of-Use Asset USD 2019 - 2024

Historical data

Taxonomy & unit
us-gaap: USD
Description
Amount of lessee's right to use underlying asset under operating lease.
Summary
X4 Pharmaceuticals, Inc quarterly Operating Lease, Right-of-Use Asset history and growth rate from 2019 to 2024.
  • X4 Pharmaceuticals, Inc Operating Lease, Right-of-Use Asset for the quarter ending March 31, 2024 was $5.26 M, a 23.1% decline year-over-year.
Operating Lease, Right-of-Use Asset, Quarterly (USD)
Operating Lease, Right-of-Use Asset, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q1 2024 $5.26 M -$1.58 M -23.1% Mar 31, 2024 10-Q 2024-05-07
Q4 2023 $5.65 M -$1.58 M -21.8% Dec 31, 2023 10-Q 2024-05-07
Q3 2023 $6.05 M -$1.55 M -20.4% Sep 30, 2023 10-Q 2023-11-09
Q2 2023 $6.45 M -$1.52 M -19.1% Jun 30, 2023 10-Q 2023-08-10
Q1 2023 $6.84 M -$1.5 M -18% Mar 31, 2023 10-Q 2023-05-04
Q4 2022 $7.23 M -$1.48 M -17% Dec 31, 2022 10-K 2024-03-21
Q3 2022 $7.61 M -$1.47 M -16.2% Sep 30, 2022 10-Q 2022-11-03
Q2 2022 $7.98 M -$1.45 M -15.4% Jun 30, 2022 10-Q 2022-08-04
Q1 2022 $8.34 M -$1.44 M -14.8% Mar 31, 2022 10-Q 2022-05-12
Q4 2021 $8.71 M +$750 K +9.42% Dec 31, 2021 10-K 2023-03-21
Q3 2021 $9.07 M +$849 K +10.3% Sep 30, 2021 10-Q 2021-11-04
Q2 2021 $9.43 M +$7.79 M +474% Jun 30, 2021 10-Q 2021-08-03
Q1 2021 $9.79 M +$7.99 M +443% Mar 31, 2021 10-Q 2021-05-06
Q4 2020 $7.96 M +$6 M +306% Dec 31, 2020 10-K 2022-03-17
Q3 2020 $8.22 M +$6.11 M +290% Sep 30, 2020 10-Q 2020-11-05
Q2 2020 $1.64 M -$543 K -24.8% Jun 30, 2020 10-Q 2020-08-04
Q1 2020 $1.8 M -$902 K -33.3% Mar 31, 2020 10-Q 2020-05-07
Q4 2019 $1.96 M Dec 31, 2019 10-K 2021-03-19
Q3 2019 $2.11 M Sep 30, 2019 10-Q 2019-11-07
Q2 2019 $2.19 M Jun 30, 2019 10-Q 2019-08-07
Q1 2019 $2.71 M Mar 31, 2019 10-Q 2019-05-15
* An asterisk sign (*) next to the value indicates that the value is likely invalid.